CD8A and neoplasm: First, we compared OVA-specific CD8+ T cells in the blood of tumor-free, vaccinated mice (VSV-GP-OVA) and tumor-bearing animals (VSV-GP-OVA (TBA)) either untreated (Ctrl (TBA)) or VSV-GP-OVA treated (TBA) (Figure 4B, left).